This Is Massive News for Eli Lilly Investors [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
While sales of Mounjaro and Zepbound are becoming increasingly scrutinized, I'd encourage investors to get up to speed on what else Lilly is working on. In early June, Lilly received some positive news from an advisory panel working alongside the Food and Drug Administration (FDA). Let's break down what's going on at the company, and what it could mean for long-term investors. Lilly's latest batch of positive news One of Lilly's biggest priorities right now is attaining FDA approval for donanemab. Donanemab is the company's candidate to treat Alzheimer's disease. According to media outlets, each member of the FDA panel that assessed the pros and cons of donanemab voted in favor of its use. While this does not mean that donanemab is formally approved by the FDA, the positive sentiment from this group of advisors should encourage investors. How big is the Alzheimer's disease market According to Statista, the number of people aged 65 and older in the U.S. with Alzheimer's coul
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- C2N Diagnostics Says FDA's Approval of Donanemab Highlights Its Role in Helping to Determine Alzheimer's Disease Pathology [Yahoo! Finance]Yahoo! Finance
- South Florida expert on what you need to know about new Alzheimer's drug [CBS News]CBS News
- FDA approves new drug for Alzheimer's disease: ‘Meaningful results' [FOX News]FOX News
- FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. [MSNBC.com]MSNBC.com
- ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF) STATEMENT ON FDA'S TRADITIONAL APPROVAL OF KISUNLA (DONANEMAB) [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 7/2/24 - Form 4
- 7/1/24 - Form 4
- 6/28/24 - Form 144
- LLY's page on the SEC website